From my understanding, it's an offer initiated by management (if you can class them as that), they claim the non-marketable parcels are costing the company money.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025